BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota December 18, 2020
BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference December 10, 2020
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19 September 30, 2020